Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bowen

Showing results (101-110 of 850) with videos related to

Pageof 85
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Investigation of the mechanism by which sigma ligands inhibit stimulation of phosphoinositide metabolism by muscarinic cholinergic agonistsW D Bowen, P Tolentino, P Varghese
Cancer Treatment Reports|January 1, 1981
Some considerations in the experimental approach to distinguishing between membrane transport and intracellular disposition of antineoplastic agents, with specific reference to fluorodeoxyuridine, actinomycin D, and methotrexateD Goldman, D Bowen, D A Gewirtz
Women'S Health (Hillsdale, N.J.)|January 14, 1998
Importance of psychological variables in understanding risk perceptions and breast cancer screening of African American womenD Bowen, K M Hickman, D Powers
Australian Health Review : a Publication of the Australian Hospital Association|December 8, 1996
Comparing patient satisfaction, outcomes and costs between cataract day surgery and inpatient surgery for elderly peopleY P Fan, D Boldy, D Bowen
Cancer Chemotherapy and Pharmacology|January 1, 1980
The interaction between fluoropyrimidines and methotrexate, and [4C]-formate incorporation into nucleic acids and proteinD Bowen, E Fölsch, L A Guernsey
European Journal of Cancer|July 1, 1980
fluoropyrimidine-induced antagonism to free and tightly bound methotrexate: suppression of [14C] formate incorporation into RNA and proteinD Bowen, E Fölsch, L A Guernsey
Annals of the New York Academy of Sciences|December 10, 1982
Growth factors from platelets, monocytes, and endothelium: their role in cell proliferationR Ross, E Raines, D Bowen-Pope
European Journal of Haematology|August 1, 1990
Megakaryocytopoiesis in patients with myelodysplastic syndromes (MDS) with and without del(5q)M Podolak-Dawidziak, D Geddes, D Bowen
Drug Metabolism and Drug Interactions|August 30, 2000
Interaction energy analyses of folate analog binding to human dihydrofolate reductase: contribution of the antifolate substructural regions to complex stabilityC Pitts, D Bowen, W M Southerland
Biopharmaceutics & Drug Disposition|April 13, 2000
Molecular modelling of trimethoprim complexes of human wild-type and mutant dihydrofolate reductases: identification of two subsets of binding residues in the antifolate binding siteR Pan, D Bowen, W M Southerland
Pageof 85

Showing results (101-110 of 850) with videos related to

Sort By:
Pageof 85
Progress in Clinical and Biological Research|January 1, 1990
Investigation of the mechanism by which sigma ligands inhibit stimulation of phosphoinositide metabolism by muscarinic cholinergic agonistsW D Bowen, P Tolentino, P Varghese
Cancer Treatment Reports|January 1, 1981
Some considerations in the experimental approach to distinguishing between membrane transport and intracellular disposition of antineoplastic agents, with specific reference to fluorodeoxyuridine, actinomycin D, and methotrexateD Goldman, D Bowen, D A Gewirtz
Women'S Health (Hillsdale, N.J.)|January 14, 1998
Importance of psychological variables in understanding risk perceptions and breast cancer screening of African American womenD Bowen, K M Hickman, D Powers
Australian Health Review : a Publication of the Australian Hospital Association|December 8, 1996
Comparing patient satisfaction, outcomes and costs between cataract day surgery and inpatient surgery for elderly peopleY P Fan, D Boldy, D Bowen
Cancer Chemotherapy and Pharmacology|January 1, 1980
The interaction between fluoropyrimidines and methotrexate, and [4C]-formate incorporation into nucleic acids and proteinD Bowen, E Fölsch, L A Guernsey
European Journal of Cancer|July 1, 1980
fluoropyrimidine-induced antagonism to free and tightly bound methotrexate: suppression of [14C] formate incorporation into RNA and proteinD Bowen, E Fölsch, L A Guernsey
Annals of the New York Academy of Sciences|December 10, 1982
Growth factors from platelets, monocytes, and endothelium: their role in cell proliferationR Ross, E Raines, D Bowen-Pope
European Journal of Haematology|August 1, 1990
Megakaryocytopoiesis in patients with myelodysplastic syndromes (MDS) with and without del(5q)M Podolak-Dawidziak, D Geddes, D Bowen
Drug Metabolism and Drug Interactions|August 30, 2000
Interaction energy analyses of folate analog binding to human dihydrofolate reductase: contribution of the antifolate substructural regions to complex stabilityC Pitts, D Bowen, W M Southerland
Biopharmaceutics & Drug Disposition|April 13, 2000
Molecular modelling of trimethoprim complexes of human wild-type and mutant dihydrofolate reductases: identification of two subsets of binding residues in the antifolate binding siteR Pan, D Bowen, W M Southerland
Pageof 85